홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Potassium Iodide → 7-Chloro-5-(methylthio)-2-(morpholin-4-ylmethyl)imidazo[1,2-c]pyrimidine

HRID 2389750
인쇄

반응식

HRID 2389750 반응식
[NH:1]1[CH2:6][CH2:5][O:4][CH2:3][CH2:2]1.C(N(CC)CC)C.[I-].[K+].[Cl:16][C:17]1[N:22]=[C:21]([S:23][CH3:24])[N:20]2[CH:25]=[C:26]([CH2:28]Cl)[N:27]=[C:19]2[CH:18]=1>CN(C=O)C>[Cl:16][C:17]1[N:22]=[C:21]([S:23][CH3:24])[N:20]2[CH:25]=[C:26]([CH2:28][N:1]3[CH2:6][CH2:5][O:4][CH2:3][CH2:2]3)[N:27]=[C:19]2[CH:18]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 4

HCID 4875Potassium IodideHCID 8083MorpholineHCID 8471TriethylamineHCID 592992327-Chloro-2-(chloromethyl)-5-methylsulfanyl-imidazo[1,2-c]pyrimidine

생성물 1

HCID 593129667-Chloro-5-(methylthio)-2-(morpholin-4-ylmethyl)imidazo[1,2-c]pyrimidine

시약·촉매·용매 1

HCID 6228
Dimethylformamide
용매
2회

실험 절차

158 mg (1.81 mmol) of morpholine are introduced into 10 ml of DMF at 0° C., and 367 mg (3.63 mmol) of triethylamine and a catalytic amount of potassium iodide are added. A solution of 300 mg of 7-chloro-2-(chloromethyl)-5-(methylthio)imidazo[1,2-c]pyrimidine (Example 26A) in DMF is then slowly added dropwise. The mixture is allowed to reach RT and is stirred at this temperature for a further 16 h. Purification of the crude product by preparative HPLC and drying under high vacuum result in 221.8 mg (41% of theory) of product.

후처리

  1. customto reach RT
  2. customPurification of the crude product by preparative HPLC
  3. customdrying under high vacuum
  4. customresult in 221.8 mg (41% of theory) of product

출처 및 근거

ORD 기록
ord-2b2748f8cfd1441aa27d84c42cd8ea60
출처 데이터셋
uspto-grants-2012_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08273752B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트